Phase 1

TH1902

Sponsor:

Theratechnologies

Code:

NCT04706962

Conditions

Solid Tumor

TNBC - Triple-Negative Breast Cancer

Hormone Receptor-positive Breast Cancer

Epithelial Ovarian Cancer

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TH1902

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by Theratechnologies on 2025-04-15.